Diabetes Clinical Trials in Philadelphia

Showing 21-40 of 539 trials

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Diabetes Mellitus Type 2, Childhood-Onset

George Washington University3,600 participantsStarted Oct 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

NCT06354660

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control. The study will last about 11 months and may include up to 11 visits.

Diabetes Type 2

Eli Lilly and Company537 participantsStarted Apr 2024

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Canoga Park, California, United States +45 more locations

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Diabetes Trials in Other Cities

Closed Loop and Education for Hypoglycemia Awareness Restoration

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Integrating Community Health Workers Into the Care of Children With Type 1 Diabetes

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Siplizumab in T1DM

Texts for Diabetes Control Among Homeless Persons

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in Philadelphia